111 related articles for article (PubMed ID: 2234200)
1. Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma.
Lahiri T; Banerjee S; Dasgupta PS; Ray MR
Neoplasma; 1990; 37(4):387-93. PubMed ID: 2234200
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of i.p. dopamine in mice bearing Ehrlich ascites carcinoma.
Dasgupta PS; Lahiri T
J Cancer Res Clin Oncol; 1987; 113(4):363-8. PubMed ID: 3597522
[TBL] [Abstract][Full Text] [Related]
4. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
5. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
Chakraborty P; Sk UH; Bhattacharya S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):971-80. PubMed ID: 19221751
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental murine tumors by MT81, a new mycotoxin from Penicillium nigricans.
Gupta M; Majumdar UK; Ray MR; Mukhopadhayay DK
Neoplasma; 1997; 44(5):329-33. PubMed ID: 9473795
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
8. Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine.
Lakshmi C; Deb C; Ray C; Ray MR
Neoplasma; 2005; 52(1):68-73. PubMed ID: 15739030
[TBL] [Abstract][Full Text] [Related]
9. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
Gupta M; Mazumder UK; Kumar RS; Kumar TS
Acta Pharmacol Sin; 2004 Aug; 25(8):1070-6. PubMed ID: 15301742
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids of Enhydra fluctuans exhibit anticancer activity against Ehrlich's ascites carcinoma in mice.
Sannigrahi S; Mazumder UK; Mondal A; Pal D; Mishra SL; Roy S
Nat Prod Commun; 2010 Aug; 5(8):1239-42. PubMed ID: 20839626
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
14. Fish venom (Pterios volitans) peptide reduces tumor burden and ameliorates oxidative stress in Ehrlich's ascites carcinoma xenografted mice.
Sri Balasubashini M; Karthigayan S; Somasundaram ST; Balasubramanian T; Viswanathan V; Raveendran P; Menon VP
Bioorg Med Chem Lett; 2006 Dec; 16(24):6219-25. PubMed ID: 17000104
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of anticancer efficacy of aonitine-containing agent BC1 against ascite and solid forms of Ehrlich's carcinoma.
Dasyukevich OI; Solyanik GI
Exp Oncol; 2007 Dec; 29(4):317-9. PubMed ID: 18199991
[TBL] [Abstract][Full Text] [Related]
16. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
Wick MM
Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
[TBL] [Abstract][Full Text] [Related]
17. [Combined effect of epinephrine and chalone extracted from Ehrlich ascites carcinoma administered during different time of day on cell division in the tumor].
Biks KA; Romanov IuA
Biull Eksp Biol Med; 1982 Oct; 94(10):100-2. PubMed ID: 6216926
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth enhancement and systemic responses of Ehrlich ascites carcinoma following intermittent whole body hyperthermia.
Lahiri T; Roy D; Sen S
Neoplasma; 1986; 33(2):207-16. PubMed ID: 3012385
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and antioxidant property of Curcuma caesia against Ehrlich's ascites carcinoma bearing mice.
Karmakar I; Dolai N; Suresh Kumar RB; Kar B; Roy SN; Haldar PK
Pharm Biol; 2013 Jun; 51(6):753-9. PubMed ID: 23527894
[TBL] [Abstract][Full Text] [Related]
20. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
